Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Market Cap
$3.55M
Return on Assets (ROA)
-299.21%
TTM Avg
-178.76%
3Y Avg
-127.09%
5Y Avg
-697.98%
Market Cap
$3.58M
Return on Assets (ROA)
-3.23%
TTM Avg
-3.23%
3Y Avg
-4.16%
5Y Avg
2.07%
Market Cap
$3.49M
Return on Assets (ROA)
-8.01%
TTM Avg
-37.73%
3Y Avg
-92.58%
5Y Avg
-74.07%
Market Cap
$3.49M
Return on Assets (ROA)
-19.43%
TTM Avg
-90.07%
3Y Avg
-138.72%
5Y Avg
-110.42%
Market Cap
$3.63M
Return on Assets (ROA)
-194.09%
TTM Avg
-543.36%
3Y Avg
-310.28%
5Y Avg
-256.27%
Market Cap
$3.62M
Return on Assets (ROA)
-67.51%
TTM Avg
-41.84%
3Y Avg
-44.47%
5Y Avg
-41.13%
Market Cap
$3.67M
Return on Assets (ROA)
-206.55%
TTM Avg
-205.58%
3Y Avg
-343.02%
5Y Avg
-343.02%
Market Cap
$3.32M
Return on Assets (ROA)
-34.54%
TTM Avg
-27.85%
3Y Avg
-120.45%
5Y Avg
-88.60%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.55M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.55M | -299.21% | -178.76% | -127.09% | -697.98% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.58M | -3.23% | -3.23% | -4.16% | 2.07% |
| Moolec Science S.A. (MLEC)vs › | $3.49M | -8.01% | -37.73% | -92.58% | -74.07% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -19.43% | -90.07% | -138.72% | -110.42% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.63M | -194.09% | -543.36% | -310.28% | -256.27% |
| Evogene Ltd. (EVGN)vs › | $3.62M | -67.51% | -41.84% | -44.47% | -41.13% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.67M | -206.55% | -205.58% | -343.02% | -343.02% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.32M | -34.54% | -27.85% | -120.45% | -88.60% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.24M | -111.26% | -147.41% | -127.90% | -106.52% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
